These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34568149)

  • 1. Comparative role of tenofovir versus entecavir for treating patients with hepatitis B virus-related acute on chronic liver failure.
    Hossain SMS; Mahtab MA; Das DC; Noor-E-Alam SM; Mamun AA; Khan MSI; Akbar SMF; Rahman MZ; Rahman S
    J Family Med Prim Care; 2021 Jul; 10(7):2642-2645. PubMed ID: 34568149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of tenofovir alafenamide and entecavir for hepatitis B virus
    Peng W; Gu H; Jiang C; Liu J; Zhang J; Fu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):194-201. PubMed ID: 35545409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenofovir Versus Entecavir for the Treatment of Acute-on-Chronic Liver Failure due to Reactivation of Chronic Hepatitis B With Genotypes B and C.
    Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Wu XN; Yang JH
    J Clin Gastroenterol; 2019 Apr; 53(4):e171-e177. PubMed ID: 29659382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
    Zhang Y; Hu XY; Zhong S; Yang F; Zhou TY; Chen G; Wang YY; Luo JX
    World J Gastroenterol; 2014 Apr; 20(16):4745-52. PubMed ID: 24782628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure.
    Malakar D; Mahtab MA; Manik AH; Alam SMNE; Das DC; Mamun AA; Khan MSI; Rahman Z; Rahman S; Akbar SMF
    J Family Med Prim Care; 2021 Jun; 10(6):2381-2385. PubMed ID: 34322442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype Matters in Patients with Acute-on-chronic Liver Failure Due to Reactivation of Chronic Hepatitis B.
    Wan YM; Li YH; Xu ZY; Wu HM; Wu XN; Xu Y
    Clin Transl Gastroenterol; 2018 Nov; 9(11):202. PubMed ID: 30416197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study.
    Wu IT; Hu TH; Hung CH; Lu SN; Wang JH; Lee CM; Chen CH
    Clin Microbiol Infect; 2017 Jul; 23(7):464-469. PubMed ID: 28189857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B.
    Li J; Hu C; Chen Y; Zhang R; Fu S; Zhou M; Gao Z; Fu M; Yan T; Yang Y; Li J; Liu J; Chen T; Zhao Y; He Y
    BMC Infect Dis; 2021 Jun; 21(1):567. PubMed ID: 34126939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure.
    Lai J; Yan Y; Mai L; Zheng YB; Gan WQ; Ke WM
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):154-9. PubMed ID: 23558069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure.
    Manik AH; Malakar D; Noor-E-Alam SM; Mahtab MA; Das DC; Mamun AA; Khan S; Akbar MF; Rahman Z; Rahman S
    J Family Med Prim Care; 2021 Jun; 10(6):2376-2380. PubMed ID: 34322441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
    Garg H; Sarin SK; Kumar M; Garg V; Sharma BC; Kumar A
    Hepatology; 2011 Mar; 53(3):774-80. PubMed ID: 21294143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis.
    Goyal SK; Dixit VK; Shukla SK; Ghosh J; Behera M; Tripathi M; Gupta N; Ranjan A; Jain AK
    Indian J Gastroenterol; 2015 Jul; 34(4):286-91. PubMed ID: 26243587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis.
    Köklü S; Tuna Y; Gülşen MT; Demir M; Köksal AŞ; Koçkar MC; Aygün C; Coban S; Ozdil K; Ataseven H; Akin E; Pürnak T; Yüksel I; Ataseven H; Ibiş M; Yildirim B; Nadir I; Küçükazman M; Akbal E; Yüksel O; Başar O; Alkan E; Baykal O
    Clin Gastroenterol Hepatol; 2013 Jan; 11(1):88-94. PubMed ID: 23063679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.
    Keating GM
    Drugs; 2011 Dec; 71(18):2511-29. PubMed ID: 22141390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B.
    Lin B; Pan CQ; Xie D; Xie J; Xie S; Zhang X; Wu B; Lin C; Gao Z
    Hepatol Int; 2013 Jun; 7(2):460-7. PubMed ID: 26201778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients?
    Yan Y; Mai L; Zheng YB; Zhang SQ; Xu WX; Gao ZL; Ke WM
    World J Gastroenterol; 2012 Sep; 18(33):4604-9. PubMed ID: 22969236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t) ide-naïve patients with chronic hepatitis B.
    Kwon YJ; Lee HS; Park MJ; Shim SG
    Niger J Clin Pract; 2015; 18(6):796-801. PubMed ID: 26289520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized open label trial of tenofovir monotherapy versus tenofovir plus telbivudine in spontaneous reactivation of hepatitis B.
    Jindal A; Vyas A; Sharma M; Kumar G; Sarin SK
    Saudi J Gastroenterol; 2019; 25(5):319-326. PubMed ID: 31044748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B.
    Doğan ÜB; Kara B; Gümürdülü Y; Soylu A; Akin MS
    Turk J Gastroenterol; 2012 Jun; 23(3):247-52. PubMed ID: 22798114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis.
    Hyun JJ; Seo YS; Yoon E; Kim TH; Kim DJ; Kang HS; Jung ES; Kim JH; An H; Kim JH; Yim HJ; Yeon JE; Lee HS; Byun KS; Um SH; Kim CD; Ryu HS
    Liver Int; 2012 Apr; 32(4):656-64. PubMed ID: 22099071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.